Waters
Waters Corporation is an American analytical laboratory instrument and software company that designs, manufactures, and sells high-performance liquid chromatography, mass spectrometry, and thermal analysis systems. The company structures its operational business through two principal reporting segments: Waters, which focuses on liquid chromatography and mass spectrometry, and TA Instruments, which specializes in thermal analysis and rheology systems. Its primary revenue drivers comprise instrument system sales, recurring sales of chromatography columns and chemistry consumables, software license subscriptions, and instrument maintenance service contracts. Servicing life science, pharmaceutical, industrial, academic, and government laboratory clients worldwide, the enterprise holds leading global market positions in high-performance analytical separation technologies and materials characterization instruments. The company maintains an extensive global commercial distribution network alongside advanced manufacturing facilities in the United States, Europe, and Asia. The corporation maintains its central executive headquarters in Milford, Massachusetts, United States, and its common stock is listed and traded on the New York Stock Exchange under the ticker symbol WAT.
60 of the funds FundTelligence covers report a position in Waters.
- Legal name
- Waters Corp.
- Sector
- Health Care
- Country
- United States
- Funds holding it
- 60
Funds holding Waters
- Aberdeen Global Small & Mid-Cap SDG Horizons Equity Fund — Abrdn · 4.2 % (largest positions only, September 2026)
- Nordea Sustainable Water — Nordea Funds · 2.09 % (full portfolio disclosed, September 2026)
- T. Rowe Price US Smaller Companies Equity Fund — T. Rowe Price · 1.93 % (full portfolio disclosed, September 2026)
- Schroder ISF Healthcare Innovation — Schroders · 1.53 % (full portfolio disclosed, June 2026)
- BNP Global Environment — BNP Paribas · 1.37 % (full portfolio disclosed, December 2025)
- Handelsbanken Amerika Tema — Handelsbanken · 1.34 % (full portfolio disclosed, October 2026)
- Handelsbanken Helse Tema — Handelsbanken · 1.25 % (full portfolio disclosed, October 2026)
- T. Rowe Price US Large Cap Value — T. Rowe Price · 0.93 % (full portfolio disclosed, September 2026)
Showing the 8 largest of 60 funds holding it.